Detection of
antibodies using immunofluoresence tests (IFAT) is recommended for diagnosis of
chronic Q fever, but other commercial antibody assays are also available. We compared an
enzyme-linked
immunosorbent assay (ELISA) (Virion/Serion) and a
complement fixation test (CFT) (Virion/Serion) for the detection of Coxiella burnetii
IgG phase I and
IgA phase I in early- and follow-up serum samples from patients with
chronic Q fever, diagnosed according to an algorithm that involves IFAT. For this, we tested sera of 49 patients, including 30 proven, 14 probable and five possible
chronic Q fever cases. Sensitivity of CFT for diagnosis of
chronic Q fever was suboptimal (85 %), as eight patients, including five with
chronic Q fever, tested negative at time of diagnosis, whereas
IgG phase I
antibodies were detected in these five patients by ELISA. Sensitivity of ELISA was higher, although three probable patients were missed. No differences in ELISA
IgA phase I detection between proven
chronic Q fever and probable were observed; instead possible patients were in majority
IgA negative (60 %). Serological examination using ELISA and CFT in follow-up sera from 26 patients on treatment was unsatisfactory. Like IFAT, all kinetic options were possible: decreasing, remaining stable or even increase during time. This study demonstrated that the sensitivity of CFT-based phase I antibody detection is low and therefore not recommended for diagnosis of
chronic Q fever. Based on our results, serological follow-up to guide treatment decisions was of limited value.